Literature DB >> 17064966

Triggers of inflammation after renal ischemia/reperfusion.

Joshua M Thurman1.   

Abstract

Renal ischemia/reperfusion (I/R) is a common cause of acute renal failure (ARF). Ischemic ARF is associated with tubulointerstitial inflammation, and studies using animal models have demonstrated that the inflammatory response to I/R exacerbates the resultant renal injury. Ischemic ARF involves complement activation, the generation of cytokines and chemokines within the kidney, and infiltration of the kidney by leukocytes. Recent work has revealed some of the events and signals that trigger the inflammatory response to aseptic, hypoxic injury of the kidney. In many ways, the inflammatory reaction to this injury resembles that seen during ascending urinary infection, and it may represent a general response of the tubular epithelial cells (TECs) to stress or injury. A greater understanding of the signals that trigger the inflammatory response may permit the development of effective therapies to ameliorate ischemic ARF.

Entities:  

Mesh:

Year:  2006        PMID: 17064966      PMCID: PMC1888143          DOI: 10.1016/j.clim.2006.09.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  75 in total

1.  Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury.

Authors:  Roshni R Molls; Vladimir Savransky; Manchang Liu; Shannon Bevans; Tulsi Mehta; Rubin M Tuder; Landon S King; Hamid Rabb
Journal:  Am J Physiol Renal Physiol       Date:  2005-12-20

2.  Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products.

Authors:  P Chowdhury; S H Sacks; N S Sheerin
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  Detection of intestinal bacterial translocation in subclinical ischemia-reperfusion using the polymerase chain reaction technique.

Authors:  M Küçükaydin; C Kocaoğlu; F Köksal; O Kontaş
Journal:  J Pediatr Surg       Date:  2000-01       Impact factor: 2.545

4.  Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins.

Authors:  Sandra Villanueva; Carlos Céspedes; Carlos P Vio
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-11-10       Impact factor: 3.619

5.  Acute tubular necrosis is characterized by activation of the alternative pathway of complement.

Authors:  Joshua M Thurman; M Scott Lucia; Danica Ljubanovic; V Michael Holers
Journal:  Kidney Int       Date:  2005-02       Impact factor: 10.612

6.  Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion.

Authors:  K K Donnahoo; X Meng; A Ayala; M P Cain; A H Harken; D R Meldrum
Journal:  Am J Physiol       Date:  1999-09

Review 7.  Heat shock (stress response) proteins and renal ischemia/reperfusion injury.

Authors:  Katherine J Kelly
Journal:  Contrib Nephrol       Date:  2005       Impact factor: 1.580

8.  Ischemia-reperfusion injury activates innate immunity in rat kidneys.

Authors:  Byung Soo Kim; Sun Woo Lim; Can Li; Jung Shim Kim; Bo Kyung Sun; Kyung Ohk Ahn; Sang Woo Han; Jin Kim; Chul Woo Yang
Journal:  Transplantation       Date:  2005-05-27       Impact factor: 4.939

9.  Intestinal reperfusion injury is mediated by IgM and complement.

Authors:  J P Williams; T T Pechet; M R Weiser; R Reid; L Kobzik; F D Moore; M C Carroll; H B Hechtman
Journal:  J Appl Physiol (1985)       Date:  1999-03

10.  Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level.

Authors:  M Girndt; U Sester; H Kaul; H Köhler
Journal:  J Am Soc Nephrol       Date:  1998-09       Impact factor: 10.121

View more
  92 in total

1.  AS-IV protects against kidney IRI through inhibition of NF-κB activity and PUMA upregulation.

Authors:  Yan Xin; Gang Li; Hongxiu Liu; Dengbin Ai
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 2.  Review: Complement and its regulatory proteins in kidney diseases.

Authors:  Allison M Lesher; Wen-Chao Song
Journal:  Nephrology (Carlton)       Date:  2010-10       Impact factor: 2.506

Review 3.  Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells.

Authors:  Antoine Monsel; Ying-Gang Zhu; Stephane Gennai; Qi Hao; Jia Liu; Jae W Lee
Journal:  Anesthesiology       Date:  2014-11       Impact factor: 7.892

Review 4.  Complement as a multifaceted modulator of kidney transplant injury.

Authors:  Paolo Cravedi; Peter S Heeger
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

5.  Fresh and cryopreserved, uncultured adipose tissue-derived stem and regenerative cells ameliorate ischemia-reperfusion-induced acute kidney injury.

Authors:  Zheng Feng; Joey Ting; Zeni Alfonso; Brian M Strem; John K Fraser; Joshua Rutenberg; Hai-Chien Kuo; Kai Pinkernell
Journal:  Nephrol Dial Transplant       Date:  2010-10-04       Impact factor: 5.992

Review 6.  Organ cross talk and remote organ damage following acute kidney injury.

Authors:  Rele Ologunde; Hailin Zhao; Kaizhi Lu; Daqing Ma
Journal:  Int Urol Nephrol       Date:  2014-06-26       Impact factor: 2.370

Review 7.  The innate immune response in ischemic acute kidney injury.

Authors:  Hye Ryoun Jang; Hamid Rabb
Journal:  Clin Immunol       Date:  2008-10-14       Impact factor: 3.969

8.  Modulation of inflammatory response by selective inhibition of cyclooxygenase-1 and cyclooxygenase-2 in acute kidney injury.

Authors:  Carla Q Feitoza; Patricia Semedo; Giselle M Gonçalves; Marcos A Cenedeze; Hélady S Pinheiro; Oscar Fernando Pavão Dos Santos; Richardt Gama Landgraf; Alvaro Pacheco-Silva; Niels Olsen Saraiva Câmara
Journal:  Inflamm Res       Date:  2009-08-27       Impact factor: 4.575

9.  Necrotic renal epithelial cell inhibits renal interstitial fibroblast activation: role of protein tyrosine phosphatase 1B.

Authors:  Murugavel Ponnusamy; Li Ma; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-02

Review 10.  Mesenchymal stromal cells: current understanding and clinical status.

Authors:  Husein K Salem; Chris Thiemermann
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.